Impact of Disease-Modifying Therapies on Gut–Brain Axis in Multiple Sclerosis

Multiple sclerosis is a chronic, autoimmune-mediated, demyelinating disease whose pathogenesis remains to be defined. In past years, in consideration of a constantly growing number of patients diagnosed with multiple sclerosis, the impacts of different environmental factors in the pathogenesis of th...

Full description

Bibliographic Details

Published in:	Medicina
Main Authors:	Ilaria Del Negro, Sara Pez, Salvatore Versace, Alessandro Marziali, Gian Luigi Gigli, Yan Tereshko, Mariarosaria Valente
Format:	Article
Language:	English
Published:	MDPI AG 2023-12-01
Subjects:	multiple sclerosis disease-modifying therapies gut–brain axis
Online Access:	https://www.mdpi.com/1648-9144/60/1/6